Cambridge Healthtech Institute’s 2nd Annual

mRNA Design & Delivery

Increased Efficacy, Better Stability, Targeted Delivery, Improved Safety

March 13-14, 2024

The success of messenger RNA (mRNA) vaccines to fight the SARS-CoV-2 pandemic has spurred interest in pursuing mRNA as a therapy for diseases like cancer, rare genetic disorders, autoimmunity, and more. The development timeline for mRNA drugs can be faster than small molecules, however, challenges need to be addressed before it can make it to the market. Cambridge Healthtech Institute’s conference on mRNA Design & Delivery focuses on the efforts that are underway to modify and deliver mRNA in ways that make it more efficacious, safe, and targeted for diverse disease indications.

For more details on the conference, please contact:

Tanuja Koppal, PhD

Senior Conference Director

Cambridge Healthtech Institute

Email: tkoppal@healthtech.com

For sponsorship information, please contact:

Kristin Skahan

Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-5431

Email: kskahan@healthtech.com